Lista de obras - Gheath Alatrash - Dominio Público Uruguay

A novel HLA-A*0201 restricted peptide derived from cathepsin G is an effective immunotherapeutic target in acute myeloid leukemia.

artículo científico publicado en 2012

A novel TCR-like CAR with specificity for PR1/HLA-A2 effectively targets myeloid leukemia in vitro when expressed in human adult peripheral blood and cord blood T cells

artículo científico publicado en 2016

A novel drug delivery system using IL-2 activated NK cells and Zyn-linked doxorubicin

artículo científico publicado en 2000

Activity of 8F4, a T-cell receptor-like anti-PR1/HLA-A2 antibody, against primary human AML in vivo

scientific article published on 08 March 2016

Adoptive T-cell therapy for Leukemia

artículo científico publicado en 2014

Adoptive transfer of PR1 cytotoxic T lymphocytes associated with reduced leukemia burden in a mouse acute myeloid leukemia xenograft model

artículo científico publicado en 2010

Allogeneic Transplantation after Myeloablative Rituximab/BEAM ± Bortezomib for Patients with Relapsed/Refractory Lymphoid Malignancies: 5-Year Follow-Up Results

artículo científico publicado en 2019

An anti–PR1/HLA-A2 T-cell receptor–like antibody mediates complement-dependent cytotoxicity against acute myeloid leukemia progenitor cells ⬇️

artículo científico publicado el 4 de febrero de 2011

Bendamustine added to allogeneic conditioning improves long-term outcomes in patients with CLL.

artículo científico publicado en 2016

Breast cancer cell uptake of the inflammatory mediator neutrophil elastase triggers an anticancer adaptive immune response ⬇️

artículo científico publicado el 7 de mayo de 2012

Breast cancer vaccines: ongoing National Cancer Institute-registered clinical trials.

artículo científico publicado en 2011

Broad cross-presentation of the hematopoietically derived PR1 antigen on solid tumors leads to susceptibility to PR1-targeted immunotherapy.

artículo científico publicado en 2012

Cancer immunotherapies, their safety and toxicity.

artículo científico publicado en 2013

Cathepsin G is broadly expressed in acute myeloid leukemia and is an effective immunotherapeutic target.

artículo científico publicado en 2016

Clinical and immunologic effects of subcutaneously administered interleukin-12 and interferon alfa-2b: phase I trial of patients with metastatic renal cell carcinoma or malignant melanoma

artículo científico publicado en 2004

Combined chemo/anti-angiogenic cancer therapy against Lewis lung carcinoma (3LL) pulmonary metastases.

artículo científico publicado en 2002

Common minor histocompatibility antigen discovery based upon patient clinical outcomes and genomic data.

artículo científico publicado en 2011

Cooperation of urokinase plasminogen activator and matrix metalloproteinases in NK cell invasion

artículo científico publicado en 2000

Cyclic neutropenia associated with T cell immunity to granulocyte proteases and a double de novo mutation in GFI1, a transcriptional regulator of ELANE

artículo científico publicado en 2010

Fucosylation enhances activity of cytotoxic T lymphocytes against breast cancer

artículo científico publicado en 2015

IL-2-mediated upregulation of uPA and uPAR in natural killer cells

artículo científico publicado en 2002

Immune aspects of the breast tumor microenvironment

artículo científico publicado en 2013

Immune checkpoints: A therapeutic target in triple negative breast cancer

artículo científico publicado en 2014

Immune rage against MAGE unleashed.

artículo científico

Immunotherapy of AML.

scientific article published on January 2010

Improved early outcomes using a T cell replete graft compared with T cell depleted haploidentical hematopoietic stem cell transplantation.

artículo científico publicado en 2012

Increasing chimerism after allogeneic stem cell transplantation is associated with longer survival time

artículo científico publicado en 2014

Long-Term Outcomes after Treatment with Clofarabine ± Fludarabine with Once-Daily Intravenous Busulfan as Pretransplant Conditioning Therapy for Advanced Myeloid Leukemia and Myelodysplastic Syndrome.

artículo científico publicado en 2016

Membrane-Associated Proteinase 3 on Granulocytes and Acute Myeloid Leukemia Inhibits T Cell Proliferation

scientific article published on 18 July 2018

Mixed T Lymphocyte Chimerism after Allogeneic Hematopoietic Transplantation Is Predictive for Relapse of Acute Myeloid Leukemia and Myelodysplastic Syndromes.

artículo científico publicado en 2015

Myeloablative reduced-toxicity i.v. busulfan-fludarabine and allogeneic hematopoietic stem cell transplant for patients with acute myeloid leukemia or myelodysplastic syndrome in the sixth through eighth decades of life

artículo científico publicado en 2011

Neutrophil elastase enhances antigen presentation by upregulating human leukocyte antigen class I expression on tumor cells

artículo científico publicado en 2016

Optimal Threshold and Time of Absolute Lymphocyte Count Assessment for Outcome Prediction after Bone Marrow Transplantation

artículo científico publicado en 2015

PR1-specific T cells are associated with unmaintained cytogenetic remission of chronic myelogenous leukemia after interferon withdrawal

artículo científico publicado en 2010

PR1-specific cytotoxic T lymphocytes are relatively frequent in umbilical cord blood and can be effectively expanded to target myeloid leukemia.

artículo científico publicado en 2016

Phase II Trial of Graft-versus-Host Disease Prophylaxis with Post-Transplantation Cyclophosphamide after Reduced-Intensity Busulfan/Fludarabine Conditioning for Hematological Malignancies.

artículo científico publicado en 2015

Phase Ib trial of folate binding protein (FBP)-derived peptide vaccines, E39 and an attenuated version, E39': An analysis of safety and immune response

artículo científico publicado en 2018

Platelet recovery before allogeneic stem cell transplantation predicts posttransplantation outcomes in patients with acute myelogenous leukemia and myelodysplastic syndrome.

artículo científico publicado en 2011

Reduced intensity vs. myeloablative conditioning with fludarabine and PK-guided busulfan in allogeneic stem cell transplantation for patients with AML/MDS

artículo científico publicado en 2018

Results of a 2-arm, phase 2 clinical trial using post-transplantation cyclophosphamide for the prevention of graft-versus-host disease in haploidentical donor and mismatched unrelated donor hematopoietic stem cell transplantation

artículo científico publicado en 2016

Rhabdomyolysis after ingestion of "foxy," a hallucinogenic tryptamine derivative

scientific article published on 01 April 2006

Similar transplantation outcomes for acute myeloid leukemia and myelodysplastic syndrome patients with haploidentical versus 10/10 human leukocyte antigen-matched unrelated and related donors.

artículo científico publicado en 2014

Targeting human B-cell malignancies through Ig light chain-specific cytotoxic T lymphocytes

artículo científico

The Role of Antigen Cross-presentation From Leukemia Blasts on Immunity to the Leukemia-associated Antigen PR1 ⬇️

artículo científico publicado el 1 de mayo de 2012

Vaccines as consolidation therapy for myeloid leukemia.

scientific article published on February 2011

uPA and uPAR contribute to NK cell invasion through the extracellular matrix

artículo científico publicado en 2001

Lista de obras de Gheath Alatrash

A novel HLA-A*0201 restricted peptide derived from cathepsin G is an effective immunotherapeutic target in acute myeloid leukemia.

A novel TCR-like CAR with specificity for PR1/HLA-A2 effectively targets myeloid leukemia in vitro when expressed in human adult peripheral blood and cord blood T cells

A novel drug delivery system using IL-2 activated NK cells and Zyn-linked doxorubicin

Activity of 8F4, a T-cell receptor-like anti-PR1/HLA-A2 antibody, against primary human AML in vivo

Adoptive T-cell therapy for Leukemia

Adoptive transfer of PR1 cytotoxic T lymphocytes associated with reduced leukemia burden in a mouse acute myeloid leukemia xenograft model

Allogeneic Transplantation after Myeloablative Rituximab/BEAM ± Bortezomib for Patients with Relapsed/Refractory Lymphoid Malignancies: 5-Year Follow-Up Results

An anti–PR1/HLA-A2 T-cell receptor–like antibody mediates complement-dependent cytotoxicity against acute myeloid leukemia progenitor cells ⬇️

Bendamustine added to allogeneic conditioning improves long-term outcomes in patients with CLL.

Breast cancer cell uptake of the inflammatory mediator neutrophil elastase triggers an anticancer adaptive immune response ⬇️

Breast cancer vaccines: ongoing National Cancer Institute-registered clinical trials.

Broad cross-presentation of the hematopoietically derived PR1 antigen on solid tumors leads to susceptibility to PR1-targeted immunotherapy.

Cancer immunotherapies, their safety and toxicity.

Cathepsin G is broadly expressed in acute myeloid leukemia and is an effective immunotherapeutic target.

Clinical and immunologic effects of subcutaneously administered interleukin-12 and interferon alfa-2b: phase I trial of patients with metastatic renal cell carcinoma or malignant melanoma

Combined chemo/anti-angiogenic cancer therapy against Lewis lung carcinoma (3LL) pulmonary metastases.

Common minor histocompatibility antigen discovery based upon patient clinical outcomes and genomic data.

Cooperation of urokinase plasminogen activator and matrix metalloproteinases in NK cell invasion

Cyclic neutropenia associated with T cell immunity to granulocyte proteases and a double de novo mutation in GFI1, a transcriptional regulator of ELANE

Fucosylation enhances activity of cytotoxic T lymphocytes against breast cancer

IL-2-mediated upregulation of uPA and uPAR in natural killer cells

Immune aspects of the breast tumor microenvironment

Immune checkpoints: A therapeutic target in triple negative breast cancer

Immune rage against MAGE unleashed.

Immunotherapy of AML.

Improved early outcomes using a T cell replete graft compared with T cell depleted haploidentical hematopoietic stem cell transplantation.

Increasing chimerism after allogeneic stem cell transplantation is associated with longer survival time

Long-Term Outcomes after Treatment with Clofarabine ± Fludarabine with Once-Daily Intravenous Busulfan as Pretransplant Conditioning Therapy for Advanced Myeloid Leukemia and Myelodysplastic Syndrome.

Membrane-Associated Proteinase 3 on Granulocytes and Acute Myeloid Leukemia Inhibits T Cell Proliferation

Mixed T Lymphocyte Chimerism after Allogeneic Hematopoietic Transplantation Is Predictive for Relapse of Acute Myeloid Leukemia and Myelodysplastic Syndromes.

Myeloablative reduced-toxicity i.v. busulfan-fludarabine and allogeneic hematopoietic stem cell transplant for patients with acute myeloid leukemia or myelodysplastic syndrome in the sixth through eighth decades of life

Neutrophil elastase enhances antigen presentation by upregulating human leukocyte antigen class I expression on tumor cells

Optimal Threshold and Time of Absolute Lymphocyte Count Assessment for Outcome Prediction after Bone Marrow Transplantation

PR1-specific T cells are associated with unmaintained cytogenetic remission of chronic myelogenous leukemia after interferon withdrawal

PR1-specific cytotoxic T lymphocytes are relatively frequent in umbilical cord blood and can be effectively expanded to target myeloid leukemia.

Phase II Trial of Graft-versus-Host Disease Prophylaxis with Post-Transplantation Cyclophosphamide after Reduced-Intensity Busulfan/Fludarabine Conditioning for Hematological Malignancies.

Phase Ib trial of folate binding protein (FBP)-derived peptide vaccines, E39 and an attenuated version, E39': An analysis of safety and immune response

Platelet recovery before allogeneic stem cell transplantation predicts posttransplantation outcomes in patients with acute myelogenous leukemia and myelodysplastic syndrome.

Reduced intensity vs. myeloablative conditioning with fludarabine and PK-guided busulfan in allogeneic stem cell transplantation for patients with AML/MDS

Results of a 2-arm, phase 2 clinical trial using post-transplantation cyclophosphamide for the prevention of graft-versus-host disease in haploidentical donor and mismatched unrelated donor hematopoietic stem cell transplantation

Rhabdomyolysis after ingestion of "foxy," a hallucinogenic tryptamine derivative

Similar transplantation outcomes for acute myeloid leukemia and myelodysplastic syndrome patients with haploidentical versus 10/10 human leukocyte antigen-matched unrelated and related donors.

Targeting human B-cell malignancies through Ig light chain-specific cytotoxic T lymphocytes

The Role of Antigen Cross-presentation From Leukemia Blasts on Immunity to the Leukemia-associated Antigen PR1 ⬇️

Vaccines as consolidation therapy for myeloid leukemia.

uPA and uPAR contribute to NK cell invasion through the extracellular matrix